Unknown OBSERVATIONAL NCT03758534

Natural History of GACI With or Without ARHR2 or PXE

The Natural History of Generalized Arterial Calcification of Infancy (GACI) With or Without Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2) or Pseudoxanthoma Elasticum (PXE)

Sponsor: ICON plc

Conditions Autosomal Recessive Hypophosphatemic Rickets Generalized Arterial Calcification in Infancy Pseudoxanthoma Elasticum

Interventions No intervention

Updated 6 times since 2018 Last updated: Nov 28, 2018 Started: Mar 15, 2018 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03758534, this observational or N/A phase trial focuses on Autosomal Recessive Hypophosphatemic Rickets and Generalized Arterial Calcification in Infancy and remains ongoing. Sponsored by ICON plc, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Jan 2024 [monthly]

Unknown Status
Dec 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Dec 2018 — Dec 2020 [monthly]

Recruiting

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ICON plc
Universität Münster

Data source: Universität Münster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Münster, Germany